Can-DESyNe will operate distinctly from Genome Canada by administration through a newly created SynBio Centre of Innovation and Entrepreneurship (CIE). The CIE, National Synthetic Biology Steering Committee, Genome Canada Enterprise and key Partners will define the governance necessary for transparent and fair decision-making for project selection and IP ownership.

National Synthetic Biology Steering Committee 

  • Dr. Bettina Hamelin, President and CEO, Ontario Genomics (Chair) - BIO

  • Andrew Casey, President and CEO, BIOTECanada - BIO

  • Dr. Doane Chilcoat, Leader, Applied Science and Technology at Corteva Agriscience - BIO

  • Dr. Krishna Mahadevan, Professor, University of Toronto - BIO

  • Dr. Vincent Martin, Director, Centre for Applied Synthetic Biology, Concordia University - BIO

  • Dr. Keith Pardee, Canada Research Chair in Synthetic Biology and Human Health, University of Toronto - BIO

  • Dr. Roman Szumski, VP Life Sciences, National Research Council - BIO

  • Dr. Steve Webb, Executive Director and Chief Executive Officer, Global Institute for Food Security - BIO

  • Dr. Peter Zandstra, Director, Michael Smith Laboratories, University of British Columbia - BIO

GOVERNANCE

PAST WEBINARS

2020WebinarSeries_VIDEO.jpg

On September 28, 2020 we were thrilled to partner with the Gairdner Foundation to bring you one of their Global Perspectives Panels as our first Canada's Bio-Revolution 2020 Webinar Series. "Editing our Economic Future: The Power of CRISPR” showcased a conversation between Gairdner Foundation laureates and leading Canadian researchers on using the opportunities and applications of gene editing, specifically by using CRISPR/Cas9, to transform multiple sectors, from therapeutics to diagnostics, agriculture, and low carbon manufacturing, all of which have a profound impact on our economy.

 

This discussion centred on the development of these molecular tools and their applications, and potential challenges to adoption. In addition, Canadian researchers spoke about how they are applying gene editing to address problems like cancer treatment and fungal resistance for crops.

 

This webinar was moderated by Dr. Janet Rossant, President and Scientific Director, Gairdner Foundation and featured expert speakers such as:

Additionally, Dr. Bettina Hamelin, Ontario Genomics, President and CEO, shared her remarks about the importance of CRISPR in shaping our economic future. In case you missed this virtual event, you can watch it here on demand.

661 University Avenue, Suite 490, Toronto, ON M5G 1M1  |  416-977-9582

©2020 by CAN-DESyNe   |   contact@candesyne.ca